BG101787A - Aprotinine options having improved properties - Google Patents
Aprotinine options having improved propertiesInfo
- Publication number
- BG101787A BG101787A BG101787A BG10178797A BG101787A BG 101787 A BG101787 A BG 101787A BG 101787 A BG101787 A BG 101787A BG 10178797 A BG10178797 A BG 10178797A BG 101787 A BG101787 A BG 101787A
- Authority
- BG
- Bulgaria
- Prior art keywords
- aprotinine
- options
- improved properties
- improvedenzymoinhibiting
- andto
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
- C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19629982A DE19629982A1 (de) | 1996-07-25 | 1996-07-25 | Aprotinin-Varianten mit verbesserten Eigenschaften |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG101787A true BG101787A (en) | 1998-10-30 |
Family
ID=7800774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101787A BG101787A (en) | 1996-07-25 | 1997-07-22 | Aprotinine options having improved properties |
Country Status (37)
| Country | Link |
|---|---|
| US (2) | US6482798B2 (cs) |
| EP (1) | EP0821007B1 (cs) |
| JP (1) | JPH10101700A (cs) |
| KR (1) | KR980009283A (cs) |
| CN (1) | CN1172116A (cs) |
| AR (1) | AR008783A1 (cs) |
| AT (1) | ATE260975T1 (cs) |
| AU (2) | AU2870197A (cs) |
| BG (1) | BG101787A (cs) |
| BR (1) | BR9704068A (cs) |
| CA (1) | CA2207071A1 (cs) |
| CO (1) | CO4890857A1 (cs) |
| CZ (1) | CZ236797A3 (cs) |
| DE (2) | DE19629982A1 (cs) |
| DZ (1) | DZ2276A1 (cs) |
| EE (1) | EE9700177A (cs) |
| ES (1) | ES2217350T3 (cs) |
| HN (1) | HN1997000094A (cs) |
| HR (1) | HRP970384A2 (cs) |
| HU (1) | HUP9701290A3 (cs) |
| ID (1) | ID17508A (cs) |
| IL (1) | IL121361A0 (cs) |
| MA (1) | MA24279A1 (cs) |
| NO (1) | NO973426L (cs) |
| NZ (1) | NZ328402A (cs) |
| PE (1) | PE92298A1 (cs) |
| PL (1) | PL321341A1 (cs) |
| RU (1) | RU2197983C2 (cs) |
| SG (1) | SG71714A1 (cs) |
| SK (1) | SK101997A3 (cs) |
| SV (1) | SV1997000068A (cs) |
| TN (1) | TNSN97130A1 (cs) |
| TR (1) | TR199700688A2 (cs) |
| TW (1) | TW480271B (cs) |
| UA (1) | UA55380C2 (cs) |
| YU (1) | YU31697A (cs) |
| ZA (1) | ZA976585B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19725014A1 (de) * | 1997-06-13 | 1998-12-17 | Bayer Ag | Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten |
| US6974188B2 (en) * | 2003-08-13 | 2005-12-13 | Cosco Management, Inc. | Chair with pivotable chair back |
| US20060218667A1 (en) * | 2004-10-12 | 2006-09-28 | Vojdani Fakhrieh S | Plant-produced recombinant aprotinin and aprotinin variants |
| WO2006042327A2 (en) * | 2004-10-12 | 2006-04-20 | Large Scale Biology Corporation | Plant-produced recombinant aprotinin and aprotinin variants |
| CN101160403B (zh) * | 2005-02-18 | 2014-08-13 | 安吉奥开米公司 | 转运化合物穿过血脑屏障的分子 |
| WO2008077478A1 (en) * | 2006-12-22 | 2008-07-03 | Bayer Schering Pharma Aktiengesellschaft | Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene |
| WO2008110301A1 (de) * | 2007-03-13 | 2008-09-18 | Bayer Schering Pharma Aktiengesellschaft | Aprotinin-varianten mit verbesserten eigenschaften |
| DE102007056231A1 (de) | 2007-09-08 | 2009-03-12 | Bayer Healthcare Ag | Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI) |
| BRPI1103921A2 (pt) | 2011-08-17 | 2013-08-06 | Mahle Metal Leve Sa | camisa de cilindro e liga de ferro fundido |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU560584B2 (en) | 1983-07-28 | 1987-04-09 | Bayer Aktiengesellschaft | Homologues of aprotinin |
| US4595974A (en) * | 1984-09-10 | 1986-06-17 | Burroughs Corporation | Base drive circuit for a switching power transistor |
| GB2208511A (en) | 1987-08-07 | 1989-04-05 | Bayer Ag | Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology |
| DK225488D0 (da) * | 1988-04-26 | 1988-04-26 | Novo Industri As | Polypeptid |
| US5591603A (en) | 1987-08-28 | 1997-01-07 | Novo Nordisk A/S | Process for preparing aprotinin and aprotinin analogs in yeast cells |
| DK463887D0 (da) | 1987-09-07 | 1987-09-07 | Novo Industri As | Gaerleader |
| DK105489D0 (da) | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
| DE3930522A1 (de) * | 1989-09-13 | 1991-03-21 | Bayer Ag | Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben |
| US5231010A (en) | 1989-09-13 | 1993-07-27 | Bayer Aktiengesellschaft | Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof |
| IL99585A0 (en) * | 1990-10-01 | 1992-08-18 | Novo Nordisk As | Aprotinin analogues,their production and pharmaceutical compositions containing them |
| WO1994001461A1 (en) * | 1992-07-13 | 1994-01-20 | Corvas International, Inc. | BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa |
| KR100199565B1 (ko) * | 1994-08-19 | 1999-06-15 | 차동천 | 승화형 감열전사 기록용 수용지의 중간층 제조방법 |
-
1996
- 1996-07-25 DE DE19629982A patent/DE19629982A1/de not_active Withdrawn
-
1997
- 1997-06-20 HN HN1997000094A patent/HN1997000094A/es unknown
- 1997-07-14 AT AT97111980T patent/ATE260975T1/de not_active IP Right Cessation
- 1997-07-14 DE DE59711356T patent/DE59711356D1/de not_active Expired - Fee Related
- 1997-07-14 EP EP97111980A patent/EP0821007B1/de not_active Expired - Lifetime
- 1997-07-14 ES ES97111980T patent/ES2217350T3/es not_active Expired - Lifetime
- 1997-07-15 HR HR19629982.9A patent/HRP970384A2/xx not_active Application Discontinuation
- 1997-07-17 US US08/896,322 patent/US6482798B2/en not_active Expired - Fee Related
- 1997-07-17 AU AU28701/97A patent/AU2870197A/en not_active Abandoned
- 1997-07-21 SV SV1997000068A patent/SV1997000068A/es unknown
- 1997-07-22 BG BG101787A patent/BG101787A/xx unknown
- 1997-07-22 ID IDP972548A patent/ID17508A/id unknown
- 1997-07-22 JP JP9210197A patent/JPH10101700A/ja active Pending
- 1997-07-22 CA CA002207071A patent/CA2207071A1/en not_active Abandoned
- 1997-07-22 IL IL12136197A patent/IL121361A0/xx unknown
- 1997-07-23 NZ NZ328402A patent/NZ328402A/xx unknown
- 1997-07-23 AR ARP970103329A patent/AR008783A1/es not_active Application Discontinuation
- 1997-07-23 DZ DZ970126A patent/DZ2276A1/fr active
- 1997-07-23 YU YU31697A patent/YU31697A/sh unknown
- 1997-07-24 UA UA97073949A patent/UA55380C2/uk unknown
- 1997-07-24 KR KR1019970034643A patent/KR980009283A/ko not_active Application Discontinuation
- 1997-07-24 PE PE1997000661A patent/PE92298A1/es not_active Application Discontinuation
- 1997-07-24 ZA ZA9706585A patent/ZA976585B/xx unknown
- 1997-07-24 SG SG1997002627A patent/SG71714A1/en unknown
- 1997-07-24 SK SK1019-97A patent/SK101997A3/sk unknown
- 1997-07-24 RU RU97112745/14A patent/RU2197983C2/ru not_active IP Right Cessation
- 1997-07-24 TW TW086110514A patent/TW480271B/zh not_active IP Right Cessation
- 1997-07-24 TN TNTNSN97130A patent/TNSN97130A1/fr unknown
- 1997-07-24 EE EE9700177A patent/EE9700177A/xx unknown
- 1997-07-24 MA MA24733A patent/MA24279A1/fr unknown
- 1997-07-24 HU HU9701290A patent/HUP9701290A3/hu unknown
- 1997-07-24 CZ CZ972367A patent/CZ236797A3/cs unknown
- 1997-07-24 BR BR9704068A patent/BR9704068A/pt not_active IP Right Cessation
- 1997-07-24 NO NO973426A patent/NO973426L/no not_active Application Discontinuation
- 1997-07-25 CN CN97115348A patent/CN1172116A/zh active Pending
- 1997-07-25 PL PL97321341A patent/PL321341A1/xx unknown
- 1997-07-25 CO CO97042648A patent/CO4890857A1/es unknown
- 1997-07-25 TR TR97/00688A patent/TR199700688A2/xx unknown
-
2001
- 2001-06-06 AU AU51787/01A patent/AU762041B2/en not_active Ceased
-
2002
- 2002-09-23 US US10/252,967 patent/US20030096752A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG102781A (en) | Isolated dimer fibroblastactivation protein alpha and its application | |
| WO2001034646A3 (en) | Recombinant gelatins | |
| ZA9710098B (en) | Halogenopyrimidines. | |
| WO1996017072A3 (en) | Recombinant alphavirus vectors | |
| DE69534778D1 (en) | Cathepsin-02-protease | |
| BG104943A (en) | Biodegradable sustained-release alginate gels | |
| BG103914A (en) | Maintained separation of delayed gels | |
| HUP0004085A3 (en) | Novel 3,6-hemiketals from the class of 9a-azalides | |
| EP0911393A4 (en) | METHOD FOR PRODUCING AND USING A NEW PEPTIDE | |
| BG101787A (en) | Aprotinine options having improved properties | |
| ZA974084B (en) | Novel α-glucuronidases, production hereof and their uses. | |
| EP0919576A4 (en) | NEW COPOLYMER, METHOD FOR PRODUCING IT AND ITS USE | |
| IL139604A0 (en) | Novel peptides | |
| IL128500A0 (en) | Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta (b) benzofurans | |
| BG104707A (en) | Caspase-8 interacting proteins | |
| DK0942992T3 (da) | O-fucosyltransferase | |
| MX9700823A (es) | Mezclas de poliisocianatos de baja viscosidad. | |
| BG104373A (en) | Polymorphous forms of dofetilide | |
| GB2325466A (en) | Nucleotide sequence from goat liver | |
| ZA977491B (en) | Use of polyhydroxycarboxylamides as EP additives. | |
| BG102937A (en) | Zona pelucida proteins as contraceptives | |
| ZA9610510B (en) | Novel peptides, the preparation and use thereof. | |
| ZA978233B (en) | The use of protein as anti-retroviral agents. | |
| ZA9711432B (en) | Compositions for the preparation of leather. | |
| MX9702231A (es) | Nuevos trimeros de isocianato y mezclas de trimeros de isocianato, su obtencion y empleo. |